Showing results (141-150 of 245) with videos related to

Sort By:
Pageof 25
Oncology|December 20, 2017
Prophylactic Suturing Closure Is Recommended after Endoscopic Treatment of Colorectal Tumors in Patients with Antiplatelet/Anticoagulant TherapyToshiharu Sakurai, Teppei Adachi, Masashi Kono, et al.
Gastrointestinal Endoscopy|June 17, 2017
Impact of avascular areas, as measured by contrast-enhanced harmonic EUS, on the accuracy of FNA for pancreatic adenocarcinomaKen Kamata, Mamoru Takenaka, Shunsuke Omoto, et al.
Internal Medicine (Tokyo, Japan)|September 4, 2018
Erythropoietic Protoporphyria-related Hepatopathy Successfully Treated with PhlebotomyAkihiro Yoshida, Satoru Hagiwara, Tomohiro Watanabe, et al.
Liver Cancer|August 20, 2021
Immunological Microenvironment Predicts the Survival of the Patients with Hepatocellular Carcinoma Treated with Anti-PD-1 AntibodyMasahiro Morita, Naoshi Nishida, Kazuko Sakai, et al.
Liver Cancer|January 7, 2016
Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular CarcinomaTadaaki Arizumi, Kazuomi Ueshima, Tomohiro Minami, et al.
Journal of Clinical Medicine|July 2, 2021
Usefulness of the Novel Snare-over-the-Guidewire Method for Transpapillary Plastic Stent Replacement (with Video)Akihiro Yoshida, Mamoru Takenaka, Kota Takashima, et al.
Oncology|December 16, 2016
Outcome of Combination Therapy with Sofosbuvir and Ledipasvir for Chronic Type C Liver DiseaseSatoru Hagiwara, Naoshi Nishida, Tomohiro Watanabe, et al.
Digestive Diseases (Basel, Switzerland)|October 18, 2016
Outcome of Asunaprevir/Daclatasvir Combination Therapy for Chronic Liver Disease Type CSatoru Hagiwara, Naoshi Nishida, Tomohiro Watanabe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 5, 2017
Chronic Fibro-Inflammatory Responses in Autoimmune Pancreatitis Depend on IFN-α and IL-33 Produced by Plasmacytoid Dendritic CellsTomohiro Watanabe, Kouhei Yamashita, Yasuyuki Arai, et al.
International Journal of Clinical Oncology|August 18, 2023
Impact of Smad4 and p53 mutations on the prognosis of patients with pancreatic ductal adenocarcinoma undergoing chemotherapyKen Kamata, Mamoru Takenaka, Naoshi Nishida, et al.
Pageof 25